Physician profile
John D Mcallister
NPI 1184689382
$609.43
in general payments reported to CMS, 2019-2025
11 companies · $21.79 in 2025
The $21.79 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.22 · 2020: $115 · 2021: $119 · 2022: $46.63 · 2023: $146 · 2024: $84.68 · 2025: $21.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $252.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $131.07 | 2019-2023 | Jardiance, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.56 | 2019-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $87.57 | 2019-2024 | Xifaxan, Trulance |
| Novo Nordisk INC | $74.64 | 2021-2023 | Rybelsus, Ozempic |
| Amarin Pharma, INC. | $72.23 | 2020-2021 | |
| Novartis Pharmaceuticals Corporation | $34.41 | 2019-2020 | |
| Medtronic, INC. | $32.68 | 2024 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $30.53 | 2023-2024 | Farxiga, Breztri |
| Grifols USA, LLC | $21.79 | 2025 | Prolastin-C Liquid |
| Exact Sciences Corporation | $18.53 | 2023 | Cologuard Collection Kit |
| Pfizer INC. | $14.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcallister listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.